Breaking News Instant updates and real-time market news.

HAS

Hasbro

$97.68

1.24 (1.29%)

16:44
11/04/19
11/04
16:44
11/04/19
16:44

Hasbro announces offering of $875.0M of common stock

Hasbro announced it has commenced an underwritten registered public offering of $875.0M of shares of its common stock. Hasbro intends to use the net proceeds of the offering to finance, in part, its proposed acquisition of Entertainment One Ltd., and to pay related costs and expenses. The closing of the offering is not conditioned upon the consummation of the proposed acquisition. If the proposed acquisition is not consummated, Hasbro intends to use the net proceeds of the offering to repurchase its common stock or for general corporate purposes, which may include debt repayment, capital expenditures and investments. BofA Securities, J.P. Morgan Securities, and Citigroup Global Markets are acting as joint book-running managers for the offering.

HAS Hasbro
$97.68

1.24 (1.29%)

10/22/19
JEFF
10/22/19
NO CHANGE
Target $135
JEFF
Buy
Jefferies says Hasbro selloff as an 'overshoot,' would be buyers
Jefferies analyst Stephanie Wissink maintained a Buy rating and $135 price target on Hasbro following the company's Q3 results and the selloff that followed those results. The analyst noted that consumer demand is solid, and expects a "partial rebound in Q4," noting that U.S. inventory issues handicapped the Q3 results, and saying that those issues were "transitory and not systematic."
10/23/19
BMOC
10/23/19
NO CHANGE
Target $90
BMOC
Market Perform
Hasbro price target lowered to $90 from $105 at BMO Capital
BMO Capital analyst Gerrick Johnson lowered his price target on Hasbro to $90 and kept his Market Perform rating after its "sizable" sales and earnings miss in Q3, which the company attributed to the threat of tariffs disrupting its "ordering patterns". The analyst notes that investors were "surprised" that this "rock solid" company could not navigate around the trade impediments, but believes that the 17% decline in the stock price was also appropriate considering Hasbro's "stretched valuation".
10/23/19
RHCO
10/23/19
NO CHANGE
Target $102
RHCO
Hold
Hasbro price target lowered to $102 from $118 at SunTrust
SunTrust analyst Michael Swartz lowered his price target on Hasbro to $102 and kept his Hold rating after its Q3 earnings miss driven by tariff-related challenges and an "adverse mix/cost" structure. The analyst notes that the exogenous headwinds experienced by the company could not be controlled, and while he likes Hasbro's long-term investment story, he sees the risk-reward on the stock as "balanced". Swartz also lowers his FY19 and FY20 EPS views by 75c and 55c to $3.90 and $4.75 respectively.
10/28/19
KEYB
10/28/19
NO CHANGE
Target $110
KEYB
Overweight
Hasbro price target lowered to $110 from $135 at KeyBanc
KeyBanc analyst Brett Andress lowered his price target for Hasbro to $110 from $135 and maintained an Overweight rating following the company's quarterly results, telling investors in a research note that the the tariff impact was more swift and pronounced than expected, resulting in both costly shifts in customer order patterns and some cancellations, as tariff narrative gyrations create disruption across the supply chain. While the optics of the miss are "ugly," Andress says he continues to believe that underlying demand for Hasbro's properties remains intact and views it as a core leisure holding.

TODAY'S FREE FLY STORIES

IR

Ingersoll-Rand

$131.33

-0.36 (-0.27%)

08:05
12/10/19
12/10
08:05
12/10/19
08:05
Hot Stocks
Ingersoll-Rand announces CFO succession plan »

Ingersoll-Rand announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RKDA

Arcadia Biosciences

$5.34

0.05 (0.95%)

08:05
12/10/19
12/10
08:05
12/10/19
08:05
Hot Stocks
Arcadia Biosciences announces launch of 'GoodHemp' product line »

Arcadia Biosciences…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WDAY

Workday

$163.69

-2.62 (-1.58%)

08:05
12/10/19
12/10
08:05
12/10/19
08:05
Initiation
Workday initiated  »

Workday assumed with an…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

IEA

Infrastructure and Energy Alternatives

$3.71

0.015 (0.41%)

08:04
12/10/19
12/10
08:04
12/10/19
08:04
Hot Stocks
Infrastructure and Energy Alternatives announces over $115M in project awards »

Infrastructure and Energy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AGE

A.G. Edwards

$1.56

0.295 (23.32%)

, LCTX

Lineage Cell Therapeutics

$0.75

-0.0538 (-6.74%)

08:04
12/10/19
12/10
08:04
12/10/19
08:04
Hot Stocks
A.G. Edwards, Lineage Cell Therapeutics issued U.S. patent »

AgeX Therapeutics (AGE)…

AGE

A.G. Edwards

$1.56

0.295 (23.32%)

LCTX

Lineage Cell Therapeutics

$0.75

-0.0538 (-6.74%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Dec

AGCO

Agco

$75.99

-0.58 (-0.76%)

08:04
12/10/19
12/10
08:04
12/10/19
08:04
Conference/Events
Agco to host analyst meeting »

Analyst meeting to be…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Dec

BLDP

Ballard Power

$6.31

-0.24 (-3.66%)

08:03
12/10/19
12/10
08:03
12/10/19
08:03
Hot Stocks
Ballard Power signs agreement with Hydrogene de France »

Ballard Power Systems…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

IPHI

Inphi

$69.15

-1.035 (-1.47%)

08:02
12/10/19
12/10
08:02
12/10/19
08:02
Recommendations
Inphi analyst commentary  »

Inphi should be bought at…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CNSP

CNS Pharmaceuticals

$3.97

-0.01 (-0.25%)

08:02
12/10/19
12/10
08:02
12/10/19
08:02
Hot Stocks
CNS Pharmaceuticals receives positive FDA Pre-ING guidance for Berubicin »

CNS Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FOCS

Focus Financial Partners

$26.84

-0.35 (-1.29%)

08:02
12/10/19
12/10
08:02
12/10/19
08:02
Initiation
Focus Financial Partners initiated  »

Jefferies starts Focus…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CLNY

Colony Capital

$4.83

0.005 (0.10%)

08:02
12/10/19
12/10
08:02
12/10/19
08:02
Hot Stocks
Digital Colony acquires Highline do Brasil II Infraestrutura de Telecomunicacoes »

Digital Colony…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Dec

SLG

SL Green Realty

$88.60

1.665 (1.92%)

08:02
12/10/19
12/10
08:02
12/10/19
08:02
Recommendations
SL Green Realty analyst commentary  »

SL Green Realty price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ENPH

Enphase Energy

$24.03

-0.07 (-0.29%)

08:01
12/10/19
12/10
08:01
12/10/19
08:01
Conference/Events
Enphase Energy to host analyst day »

Analyst day to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Dec

WDAY

Workday

$163.69

-2.62 (-1.58%)

08:01
12/10/19
12/10
08:01
12/10/19
08:01
Initiation
Workday initiated  »

Workday assumed with an…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ARQL

ArQule

$19.71

10.035 (103.77%)

, MRK

Merck

$88.71

-0.13 (-0.15%)

08:00
12/10/19
12/10
08:00
12/10/19
08:00
Downgrade
ArQule, Merck rating change  »

ArQule downgraded to…

ARQL

ArQule

$19.71

10.035 (103.77%)

MRK

Merck

$88.71

-0.13 (-0.15%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Dec

  • 11

    Dec

  • 17

    Dec

  • 24

    Jan

  • 24

    Jan

  • 05

    Feb

  • 14

    Mar

PENN

Penn National

$23.00

-0.12 (-0.52%)

08:00
12/10/19
12/10
08:00
12/10/19
08:00
Recommendations
Penn National analyst commentary  »

Penn National price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AAPL

Apple

$266.93

-3.75 (-1.39%)

08:00
12/10/19
12/10
08:00
12/10/19
08:00
Options
Apple put buyer realizes 28% same-day gains »

Notable profits for the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TKR

Timken

$53.50

(0.00%)

07:58
12/10/19
12/10
07:58
12/10/19
07:58
Conference/Events
Timken to host investor day »

Investor day to be held…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Dec

RHP

Ryman Hospitality

$89.28

-0.6 (-0.67%)

07:58
12/10/19
12/10
07:58
12/10/19
07:58
Syndicate
Ryman Hospitality 3M share Spot Secondary priced at $85.60 »

The deal priced at low…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Dec

CHD

Church & Dwight

$70.33

0.04 (0.06%)

07:57
12/10/19
12/10
07:57
12/10/19
07:57
Downgrade
Church & Dwight rating change  »

JPMorgan downgrades…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NEWR

New Relic

$69.03

0.4 (0.58%)

07:56
12/10/19
12/10
07:56
12/10/19
07:56
Conference/Events
New Relic to host investor day »

Investor day to be held…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Dec

  • 12

    Dec

CHWY

Chewy

$24.17

-0.76 (-3.05%)

07:56
12/10/19
12/10
07:56
12/10/19
07:56
Recommendations
Chewy analyst commentary  »

Chewy short-term pullback…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Dec

07:55
12/10/19
12/10
07:55
12/10/19
07:55
Conference/Events
FDA Cardiovascular & Renal Drugs Advisory Committee to hold a meeting »

The Committee discusses…

THS

TreeHouse

$51.68

0.16 (0.31%)

07:55
12/10/19
12/10
07:55
12/10/19
07:55
Conference/Events
TreeHouse to host investor meeting »

Investor breakfast…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Dec

ALB

Albemarle

$64.71

0.405 (0.63%)

07:54
12/10/19
12/10
07:54
12/10/19
07:54
Conference/Events
Albemarle to host investor day »

Investor day to be held…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Dec

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.